Knowledgebase · FAIRsharing
Long-Acting Therapeutics Patents and Licences Database (LAPaL)
Compounds and reactions
LAPaL is a repository for information on long-acting (LA) technologies patents and licences. As of Sep 2025, it comprises 37 long-acting platform technologies and 50 LA formulations with many potential applications in the fields of HIV prevention and treatment, hepatitis B treatment, malaria treatment, type 2 diabetes and metabolic disorders management, pain management and contraception, among other applications. In 2023, and through a collaboration with the Center of Excellence of Long Acting Therapeutics and the Long-Acting/Extended Release Antiretroviral Research Resource Program, a new section was added to LAPaL, with 10 compounds with long half-life or that could be formulated in a manner that enables extended release. We are also collaborating with major initiatives and groups, such as AVAC, to synergise efforts and support the global community to deliver effectively in the HIV prevention space. Additionally, a visualisation tool (Landscape) is available for the selection of investigated and approved long-acting compounds in the HIV and TB fields and the related clinical trials. It provides information on the clinical trials pipeline of a set of compounds and filing data for the most advances products.
- Website
- Record in FAIRsharing (doi:10.25504/FAIRsharing.1d2f21)
- Subjects: Drug Discovery, Drug Repositioning, Pharmacology, Pharmacy
What is known per question
The questions of the decision tree, with what FAIRsharing says about this repository. ✓ supported, ✗ excluded, ? not known. Your own answers are marked.
What kind of data do you want to archive?
- ? Spectra
- ? Crystal structures
- ? Computational chemistry
- ? Catalysis
- ✓ Compounds and reactions
- ? Bioassays and chemical biology
- ? Materials and polymers
- ? Images and microscopy
- ? Something else
Subjects: Drug Discovery; Drug Repositioning; Pharmacology; Pharmacy
Domains: Drug name; Drug report
Does the journal or publisher you publish with require or recommend a repository?
- ? Yes
- ? No
- ? I do not know
FAIRsharing has no information on this.
Which discipline does your data belong to?
FAIRsharing has no information on this.
Which publisher?
FAIRsharing has no information on this.
Does your funder have requirements for where data is archived?
- ? Yes
- ? No
- ? I do not know
FAIRsharing has no information on this.
Which funder?
FAIRsharing has no information on this.
Does your institution offer a data repository?
- ? Yes
- ? No
- ? I do not know
FAIRsharing has no information on this.
Which institution?
FAIRsharing has no information on this.
Can your data be shared openly?
- ✓ Yes, openly available
- ? Yes, after an embargo
- ✗ Only with restrictions
Data access: open: Fully Open Access Database
Data deposition: open: Although data are curated from publicly-available sources, some deposition of content is allowed.
How large is your dataset?
- ? Less than 1 GB
- ? 1 GB to 50 GB
- ? 50 GB to 1 TB
- ? More than 1 TB
FAIRsharing has no information on this.
Why can the data not be open?
- ? It contains personal data
- ? Commercial or intellectual property reasons
- ? Safety or security concerns
- ? A data sharing agreement limits it
FAIRsharing has no information on this.
Under which license do you want to share the data?
- ? CC0 / public domain
- ✓ CC BY
- ? Another open license
- ? Not decided yet
Licences: Creative Commons Attribution 4.0 International (CC BY 4.0)
Do you need a persistent identifier, such as a DOI, for citing the data?
- ? Yes, a DOI
- ? Any persistent identifier will do
- ? No
FAIRsharing has no information on this.
Must the data be stored in a specific region?
- ✗ In the European Union
- ? In a specific country
- ✓ No preference
Country: Switzerland; United Kingdom; United States
Must archiving be free of charge?
- ? Yes, free only
- ? A fee is fine
FAIRsharing has no information on this.
Which country?
✓ 3 of 15 in the list ✗ excludes 12
Country: Switzerland; United Kingdom; United States